Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy

Patients with central serous chorioretinopathy (CSC) often complain of visual difficulties under low luminance conditions. In this study, we evaluated low luminance visual acuity (LLVA) after half-dose verteporfin photodynamic therapy (hdPDT) in eyes with CSC. The study included eight eyes of eight...

Full description

Bibliographic Details
Main Authors: Kyoko Fujita, Kei Shinoda, Yutaka Imamura, Celso Soiti Matsumoto, Koichi Oda
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/12/3980
_version_ 1797545289246048256
author Kyoko Fujita
Kei Shinoda
Yutaka Imamura
Celso Soiti Matsumoto
Koichi Oda
author_facet Kyoko Fujita
Kei Shinoda
Yutaka Imamura
Celso Soiti Matsumoto
Koichi Oda
author_sort Kyoko Fujita
collection DOAJ
description Patients with central serous chorioretinopathy (CSC) often complain of visual difficulties under low luminance conditions. In this study, we evaluated low luminance visual acuity (LLVA) after half-dose verteporfin photodynamic therapy (hdPDT) in eyes with CSC. The study included eight eyes of eight patients with chronic CSC that underwent hdPDT. The best-corrected visual acuity, LLVA and optical coherence tomography (OCT) findings were evaluated at baseline, and at 1, 3, 6, 9, and 12 months after hdPDT. LLVA was measured at six levels of background luminance. Serous retinal detachment was completely resolved in all eyes. Although the mean LLVA at 1 month did not improve significantly compared to baseline at all luminance levels, significant improvements were observed at 3, 6, 9, and 12 months (<i>p</i> < 0.05). In OCT images, although the ellipsoid zone was not detectable in all eyes before hdPDT, it was observed in 2 eyes at 1 month, in 7 eyes at 3 months, and in all eyes from 6 months. The LLVA and the ellipsoid zone improved similarly with postoperative time courses. In conclusion, hdPDT improves LLVA in eyes with chronic CSC. The recovery of the ellipsoid zone may play a part in improving LLVA after hdPDT.
first_indexed 2024-03-10T14:13:19Z
format Article
id doaj.art-15e5333a3a68455382f5fcae15f386e9
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T14:13:19Z
publishDate 2020-12-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-15e5333a3a68455382f5fcae15f386e92023-11-20T23:57:35ZengMDPI AGJournal of Clinical Medicine2077-03832020-12-01912398010.3390/jcm9123980Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic TherapyKyoko Fujita0Kei Shinoda1Yutaka Imamura2Celso Soiti Matsumoto3Koichi Oda4Department of Opthalmology, Aichi Medical University School of Medicine, Aichi 480-1195, JapanDepartment of Ophthalmology, Saitama Medical University School of Medicine, Saitama 350-0495, JapanDepartment of Ophthalmology, Teikyo University School of Medicine, University Hospital Mizonokuchi, Kanagawa 213-8507, JapanDepartment of Ophthalmology, Teikyo University School of Medicine, University Hospital Itabashi, Tokyo 173-8606, JapanDepartment of Communication, Tokyo Woman’s Christian University, Tokyo 167-8585, JapanPatients with central serous chorioretinopathy (CSC) often complain of visual difficulties under low luminance conditions. In this study, we evaluated low luminance visual acuity (LLVA) after half-dose verteporfin photodynamic therapy (hdPDT) in eyes with CSC. The study included eight eyes of eight patients with chronic CSC that underwent hdPDT. The best-corrected visual acuity, LLVA and optical coherence tomography (OCT) findings were evaluated at baseline, and at 1, 3, 6, 9, and 12 months after hdPDT. LLVA was measured at six levels of background luminance. Serous retinal detachment was completely resolved in all eyes. Although the mean LLVA at 1 month did not improve significantly compared to baseline at all luminance levels, significant improvements were observed at 3, 6, 9, and 12 months (<i>p</i> < 0.05). In OCT images, although the ellipsoid zone was not detectable in all eyes before hdPDT, it was observed in 2 eyes at 1 month, in 7 eyes at 3 months, and in all eyes from 6 months. The LLVA and the ellipsoid zone improved similarly with postoperative time courses. In conclusion, hdPDT improves LLVA in eyes with chronic CSC. The recovery of the ellipsoid zone may play a part in improving LLVA after hdPDT.https://www.mdpi.com/2077-0383/9/12/3980central serous chorioretinopathylow luminance visual acuityphotodynamic therapyellipsoid zone
spellingShingle Kyoko Fujita
Kei Shinoda
Yutaka Imamura
Celso Soiti Matsumoto
Koichi Oda
Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
Journal of Clinical Medicine
central serous chorioretinopathy
low luminance visual acuity
photodynamic therapy
ellipsoid zone
title Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
title_full Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
title_fullStr Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
title_full_unstemmed Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
title_short Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
title_sort improvement of low luminance visual acuity in patients with chronic central serous chorioretinopathy after half dose verteporfin photodynamic therapy
topic central serous chorioretinopathy
low luminance visual acuity
photodynamic therapy
ellipsoid zone
url https://www.mdpi.com/2077-0383/9/12/3980
work_keys_str_mv AT kyokofujita improvementoflowluminancevisualacuityinpatientswithchroniccentralserouschorioretinopathyafterhalfdoseverteporfinphotodynamictherapy
AT keishinoda improvementoflowluminancevisualacuityinpatientswithchroniccentralserouschorioretinopathyafterhalfdoseverteporfinphotodynamictherapy
AT yutakaimamura improvementoflowluminancevisualacuityinpatientswithchroniccentralserouschorioretinopathyafterhalfdoseverteporfinphotodynamictherapy
AT celsosoitimatsumoto improvementoflowluminancevisualacuityinpatientswithchroniccentralserouschorioretinopathyafterhalfdoseverteporfinphotodynamictherapy
AT koichioda improvementoflowluminancevisualacuityinpatientswithchroniccentralserouschorioretinopathyafterhalfdoseverteporfinphotodynamictherapy